Background The opioid crisis has severely impacted health outcomes in the United States, particularly in rural areas, where barriers to medication-based treatment for opioid use disorder (OUD) persist. Although medication-assisted treatment (MAT) for OUD is effective, access remains limited, especially in these communities. Aim This study identifies and examines barriers to accessing office-based OUD treatment in rural areas of the United States.
View Article and Find Full Text PDFBackground: Glioma, the most prevalent primary brain tumor, poses challenges in prognosis, particularly in the high-grade subclass, despite advanced treatments. The recent shift in tumor classification underscores the crucial role of isocitrate dehydrogenase (IDH) mutation status in the clinical care of glioma patients. However, conventional methods for determining IDH status, including biopsy, have limitations.
View Article and Find Full Text PDFBackground: New strains of SARS-CoV-2 are continually emerging worldwide. Recently, WHO warned of a severe new wave in Europe. Current vaccines cannot fully prevent reinfection in vaccinated individuals.
View Article and Find Full Text PDF